Search Results 1621-1630 of 16552 for Interphase

  1. A Study to Evaluate Practical Anemia Bundle for SusTained Blood Recovery - Mayo Clinic

    The purpose of this research is to test a treatment plan to help reduce further anemia (a low blood count or hemoglobin level) and to promote hemoglobin and ...

  2. EP study - Doctors & Departments - Mayo Clinic

    Areas of study have included: Leading a multicenter, multinational trial to compare drug therapy with cardiac ablation for people with heart rhythm disease.

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Brivekimig For The Treatment Of Moderate To Severe Hidradenitis Suppurativa - Mayo Clinic

    About this study. This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Publications - Julie A. Fields, Ph.D., L.P. - Mayo Clinic

    Author Correction: Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer's disease copathologies. NPJ ...

  10. A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in People With Celiac Disease - Mayo Clinic

    The purpose of this study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in ...